Free Trial

Verona Pharma PLC American Depositary Share (VRNA) Stock Price, News & Analysis

Verona Pharma PLC American Depositary Share logo
$104.80 +17.94 (+20.65%)
As of 01:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Verona Pharma PLC American Depositary Share Stock (NASDAQ:VRNA)

Key Stats

Today's Range
$104.75
$104.93
50-Day Range
$63.36
$97.22
52-Week Range
$16.61
$104.98
Volume
54.07 million shs
Average Volume
1.47 million shs
Market Capitalization
$8.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$107.36
Consensus Rating
Buy

Company Overview

Verona Pharma PLC American Depositary Share Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

VRNA MarketRank™: 

Verona Pharma PLC American Depositary Share scored higher than 38% of companies evaluated by MarketBeat, and ranked 454th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Verona Pharma PLC American Depositary Share has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Verona Pharma PLC American Depositary Share has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Verona Pharma PLC American Depositary Share's stock forecast and price target.
  • Earnings Growth

    Earnings for Verona Pharma PLC American Depositary Share are expected to grow in the coming year, from ($1.95) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Verona Pharma PLC American Depositary Share is -52.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Verona Pharma PLC American Depositary Share is -52.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Verona Pharma PLC American Depositary Share has a P/B Ratio of 40.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Verona Pharma PLC American Depositary Share's valuation and earnings.
  • Percentage of Shares Shorted

    10.39% of the float of Verona Pharma PLC American Depositary Share has been sold short.
  • Short Interest Ratio / Days to Cover

    Verona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Verona Pharma PLC American Depositary Share has recently increased by 18.09%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Verona Pharma PLC American Depositary Share does not currently pay a dividend.

  • Dividend Growth

    Verona Pharma PLC American Depositary Share does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.39% of the float of Verona Pharma PLC American Depositary Share has been sold short.
  • Short Interest Ratio / Days to Cover

    Verona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Verona Pharma PLC American Depositary Share has recently increased by 18.09%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Verona Pharma PLC American Depositary Share has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Verona Pharma PLC American Depositary Share this week, compared to 7 articles on an average week.
  • Search Interest

    Only 9 people have searched for VRNA on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.
  • MarketBeat Follows

    10 people have added Verona Pharma PLC American Depositary Share to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Verona Pharma PLC American Depositary Share insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $20,056,881.00 in company stock.

  • Percentage Held by Insiders

    Only 4.80% of the stock of Verona Pharma PLC American Depositary Share is held by insiders.

  • Percentage Held by Institutions

    85.88% of the stock of Verona Pharma PLC American Depositary Share is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Verona Pharma PLC American Depositary Share's insider trading history.
Receive VRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verona Pharma PLC American Depositary Share and its competitors with MarketBeat's FREE daily newsletter.

VRNA Stock News Headlines

Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
Merck to Buy Verona Pharma in $10 Billion Deal
See More Headlines

VRNA Stock Analysis - Frequently Asked Questions

Verona Pharma PLC American Depositary Share's stock was trading at $46.44 on January 1st, 2025. Since then, VRNA stock has increased by 125.7% and is now trading at $104.8030.

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) announced its quarterly earnings data on Tuesday, April, 29th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.49. The company earned $98.65 million during the quarter, compared to the consensus estimate of $41.47 million.
Read the conference call transcript
.

Verona Pharma PLC American Depositary Share (VRNA) raised $61 million in an initial public offering on Thursday, April 27th 2017. The company issued 4,500,000 shares at a price of $13.49 per share. Jefferies and Stifel acted as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers.

Shares of VRNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Verona Pharma PLC American Depositary Share investors own include Cisco Systems (CSCO), Philip Morris International (PM), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Home Depot (HD) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
4/29/2025
Today
7/09/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VRNA
CIK
1657312
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$170.00
Low Price Target
$57.00
Potential Upside/Downside
+23.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
12 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$173.42 million
Pretax Margin
-130.46%

Debt

Sales & Book Value

Annual Sales
$42.28 million
Price / Cash Flow
N/A
Book Value
$2.56 per share
Price / Book
33.93

Miscellaneous

Free Float
81,046,000
Market Cap
$7.39 billion
Optionable
Optionable
Beta
0.24
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:VRNA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners